" class="no-js "lang="en-US"> News Archives - Medtech Alert
Monday, June 05, 2023

Sort by:

Date

Top Post

SNIPR Biome Reports Positive Clinical Interim Results for Groundbreaking, First-in-Human, CRISPR-based Microbial Gene Therapy

SNIPR Biome, the company pioneering CRISPR microbial gene therapy, has announced positive interim clinical results […]

Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development

Providence Therapeutics, a biopharmaceutical company developing messenger RNA (mRNA) vaccines and therapeutics, today announced its […]

Affini-T Therapeutics Appoints Industry Veteran Thaminda Ramanayake, M.S., MBA, as Chief Business Officer

Affini-T Therapeutics, a precision immunotherapy company unlocking the power of T cells against oncogenic driver […]

Feinstein Institutes Bioelectronic Medicine Researchers Stimulate Vagus Nerve to Reduce Bleeding in Hemophilia

Hemophilia A, a bleeding disorder that prevents blood from clotting, affects more than 30,000 people […]

Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in Lupus Nephritis

Kyverna Therapeutics, a cell therapy company with the mission of engineering a new class of […]

Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency

Arcturus Therapeutics, a global late-stage clinical messenger RNA medicines company focused on the development of […]

CANbridge Announces Marketing Approval of CAN108 in China for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome

CANbridge Pharmaceuticals, a global biopharmaceutical company, with a foundation in China, committed to the research, […]

GC Biopharma Receives a Business License for the Construction of a Plasma Fractionation Plant and Technology Transfer in Indonesia

GC Biopharma, a South Korean biopharmaceutical company, has announced that it has successfully obtained final […]

Cytovation Raises $8 Million in Series A Extension Financing Round for Clinical Advancement of CyPep-1, a First-in-class Targeted Tumor Membrane Immunotherapy

Cytovation ASA, a clinical-stage immune-oncology company focused on the development of its first-in-class targeted tumor […]

FUJIFILM Cellular Dynamics Introduces First-of-its-Kind Human iPSC-derived Blood-Brain Barrier Isogenic Kit

FUJIFILM Cellular Dynamics, a leading global developer and manufacturer of human induced pluripotent stem cells […]

Landmark Bio Partners With InnDura Therapeutics to Advance Immune Cell Therapy Research

Landmark Bio, a collective endeavor bringing together leaders in industry, academia, and research hospitals to […]

  1. Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development Read more
  2. Affini-T Therapeutics Appoints Industry Veteran Thaminda Ramanayake, M.S., MBA, as Chief Business Officer Read more
  3. Feinstein Institutes Bioelectronic Medicine Researchers Stimulate Vagus Nerve to Reduce Bleeding in Hemophilia Read more
  4. Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in Lupus Nephritis Read more
  5. Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency Read more